Prexasertib treatment induced significant apoptosis in DLBCL cell lines irrespective of TP53 status and was associated with significant accumulation of cells in S phase of the cell cycle, in line with previous observations [51] (Fig. 3E, F and Figures S4F and S5A-F). The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.